BABY TRIBOTAN

This brand name is authorized in Nigeria.

Active ingredients

The drug BABY TRIBOTAN contains a combination of these active pharmaceutical ingredients (APIs):

1	Clotrimazole UNII G07GZ97H65 - CLOTRIMAZOLE
	Clotrimazole acts against fungi by inhibiting ergosterol synthesis. Inhibition of ergosterol synthesis leads to structural and functional impairment of the fungal cytoplasmic membrane. Clotrimazole has a broad antimycotic spectrum of action in vitro and in vivo, which includes dermatophytes, yeasts, moulds, etc.
	Read more about Clotrimazole
2	Ichthammol UNII NQ14646378 - ICHTHAMMOL

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-7018	Cream	Baby Tribotan Cream CREAM 0.2%; 0.5% 1 x 20 g (in Lami tube)	Cream 16 RNW-PP-305475 BABY TRIBOTAN CREAM CLOTRIMAZOLE 0.5% W/V , ICHTHAMMOL 0.2% W/V CLOTRIMAZOLE 0.5% W/V , ICHTHAMMOL 0.2% W/V Apr-18 Drugs Nigerian Products 20G Over The Counter (OTC) 12/28/2022 FIDSON HEALTHCARE PLC, IKORODU ROAD, OBANIKORO LAGOS LAGOS 8023067964 nmakaokolo@yahoo.com Fidson Healthcare Plc., KM 38, Lagos- Abeokuta Expressway Sango-ota, Ogun State., Nigeria	31/01/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D01AC01	Clotrimazole	D Dermatologicals → D01 Antifungals for dermatological use → D01A Antifungals for topical use → D01AC Imidazole and triazole derivatives
Discover more medicines within D01AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-7018